I'll make it a little more clear
You need an IRB to apply for compassionate use.
Revive JUST SUBMITTED the submission of the Phase 3 study protocol to Advarra, a premier IRB services. Advarra an IRB needs to approve this in order for Revive to submit for compassionate use with the FDA !!!
Come on people get your head in the game.
Advarra could respond within 24 hours
Then Revive will apply for compassionate use. FDA take take as little as 1-14 days to approve compassionate use.
Like I said, Bucillamine could be in use Mid-September.
But what do I know, right?!